The Senior Manager will support an innovative treatment approved for three rare-disease indications as it expands globally. The role supports access strategy and launch execution for approved indications and pipeline opportunities, including reimbursement expansion across more than 27 markets through 2026–2027. The position sits within the Global Integrated Access Strategy organization and reports to the Access Strategy Lead for the treatment in the Rare Disease therapeutic area. The Senior Manager will serve as a subject matter expert for assigned indications in launch phase and potential indication expansions. The role leads indication-specific Value, Access and Pricing assessments, acts as the Global Access strategy point of contact for indication-specific cross-functional working groups, and translates payer needs, competitor pricing, and policy developments in the US and priority ELMAC markets into recommendations. The role partners with global functional colleagues and country and regional access teams to shape evidence needs and country access plans and inform clinical development, early Target Product Profiles, launch strategies, and forecasts. Responsibilities also include contributing to global planning materials, leading payer research with Global Insights teams, managing external vendors as needed, and creating Global Value & Access materials such as early value stories and objection handlers. The Senior Manager presents work, helps organize team meetings, and supports best-practice sharing and discussions with local access teams, independently leading assigned workstreams from strategy through execution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
No Education Listed